http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H049361-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fb9f44db08d1c42a53f3d28eaae416f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11D1-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-10
filingDate 1990-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d997cad805e76245e6afd7b6770a9c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_861024e5867d78e9be558070659e49c4
publicationDate 1992-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H049361-A
titleOfInvention Production of amidoamine-type compound
abstract PURPOSE: To obtain the subject compound useful a surfactant having low viscosity and weak skin irritation and difficult to produce by conventional methods, in high selectivity with a simple operation at a low cost, by reacting imidazoline with a monohalogenated acetic acid in the presence of a specific inorganic salt. n CONSTITUTION: The objective compound of formula I can be produced in high selectivity by reacting (A) an imidazoline of formula III (R is 3-27C alkyl, alkenyl, hydroxyalkyl or aralkyl) such as 1-hydroxyethyl-2-undecylimidazoline with (B) a monohalogenated acetic acid of formula IV (X is halogen) such as sodium monochloroacetate or its salt at 50-100°C in (C) water or, as necessary, a solvent such as alcohol in the presence of (D) preferably about 500-5,000ppm (based on the total charged amount) of an inorganic salt of formula ZHSO 3 (Z is alkali metal), Z 2 S 2 O 3 or ZPH 2 O 2 (e.g. NaHSO 3 ) and preferably (E) an alkali such as NaOH for promoting the ring-opening reaction of the imidazoline ring. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2142266-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2760453-A1
priorityDate 1990-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23373915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8709
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227052708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408486386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233336915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448616730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414864108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 38.